435 related articles for article (PubMed ID: 16183674)
1. Fabrication, characterization, and in vitro degradation of composite scaffolds based on PHBV and bioactive glass.
Li H; Du R; Chang J
J Biomater Appl; 2005 Oct; 20(2):137-55. PubMed ID: 16183674
[TBL] [Abstract][Full Text] [Related]
2. Fabrication and characterization of bioactive wollastonite/PHBV composite scaffolds.
Li H; Chang J
Biomaterials; 2004 Nov; 25(24):5473-80. PubMed ID: 15142728
[TBL] [Abstract][Full Text] [Related]
3. A mesoporous bioactive glass/polycaprolactone composite scaffold and its bioactivity behavior.
Li X; Shi J; Dong X; Zhang L; Zeng H
J Biomed Mater Res A; 2008 Jan; 84(1):84-91. PubMed ID: 17600329
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of bioactive mesoporous wollastonite - Polycaprolactone composite scaffold.
Wei J; Chen F; Shin JW; Hong H; Dai C; Su J; Liu C
Biomaterials; 2009 Feb; 30(6):1080-8. PubMed ID: 19019424
[TBL] [Abstract][Full Text] [Related]
5. Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites.
Misra SK; Mohn D; Brunner TJ; Stark WJ; Philip SE; Roy I; Salih V; Knowles JC; Boccaccini AR
Biomaterials; 2008 Apr; 29(12):1750-61. PubMed ID: 18255139
[TBL] [Abstract][Full Text] [Related]
6. Preparation, characterization and in vitro release of gentamicin from PHBV/wollastonite composite microspheres.
Li H; Chang J
J Control Release; 2005 Oct; 107(3):463-73. PubMed ID: 16154657
[TBL] [Abstract][Full Text] [Related]
7. The fabrication and characterization of biodegradable HA/PHBV nanoparticle-polymer composite scaffolds.
Jack KS; Velayudhan S; Luckman P; Trau M; Grøndahl L; Cooper-White J
Acta Biomater; 2009 Sep; 5(7):2657-67. PubMed ID: 19375396
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional, bioactive, biodegradable, polymer-bioactive glass composite scaffolds with improved mechanical properties support collagen synthesis and mineralization of human osteoblast-like cells in vitro.
Lu HH; El-Amin SF; Scott KD; Laurencin CT
J Biomed Mater Res A; 2003 Mar; 64(3):465-74. PubMed ID: 12579560
[TBL] [Abstract][Full Text] [Related]
9. In vitro bioactivity and degradation of polycaprolactone composites containing silicate fillers.
Chouzouri G; Xanthos M
Acta Biomater; 2007 Sep; 3(5):745-56. PubMed ID: 17392042
[TBL] [Abstract][Full Text] [Related]
10. Modulation of polycaprolactone composite properties through incorporation of mixed phosphate glass formulations.
Shah Mohammadi M; Ahmed I; Marelli B; Rudd C; Bureau MN; Nazhat SN
Acta Biomater; 2010 Aug; 6(8):3157-68. PubMed ID: 20206722
[TBL] [Abstract][Full Text] [Related]
11. Crosslinked poly(epsilon-caprolactone/D,L-lactide)/bioactive glass composite scaffolds for bone tissue engineering.
Meretoja VV; Helminen AO; Korventausta JJ; Haapa-aho V; Seppälä JV; Närhi TO
J Biomed Mater Res A; 2006 May; 77(2):261-8. PubMed ID: 16392138
[TBL] [Abstract][Full Text] [Related]
12. Novel porous hydroxyapatite prepared by combining H2O2 foaming with PU sponge and modified with PLGA and bioactive glass.
Huang X; Miao X
J Biomater Appl; 2007 Apr; 21(4):351-74. PubMed ID: 16543281
[TBL] [Abstract][Full Text] [Related]
13. Surface modification of PHBV scaffolds via UV polymerization to improve hydrophilicity.
Ke Y; Wang Y; Ren L
J Biomater Sci Polym Ed; 2010; 21(12):1589-602. PubMed ID: 20537243
[TBL] [Abstract][Full Text] [Related]
14. The influence of hydroxyapatite particles on in vitro degradation behavior of poly epsilon-caprolactone-based composite scaffolds.
Guarino V; Taddei P; Di Foggia M; Fagnano C; Ciapetti G; Ambrosio L
Tissue Eng Part A; 2009 Nov; 15(11):3655-68. PubMed ID: 19496680
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of PHBV microsphere/45S5 bioactive glass composite scaffolds with vancomycin releasing function.
Li W; Ding Y; Rai R; Roether JA; Schubert DW; Boccaccini AR
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():320-8. PubMed ID: 24907766
[TBL] [Abstract][Full Text] [Related]
16. Fabrication and characterization of polysulfone-dicalcium silicate composite films.
Cheng W; Chang J
J Biomater Appl; 2006 Apr; 20(4):361-76. PubMed ID: 16443620
[TBL] [Abstract][Full Text] [Related]
17. Mineralization behavior and interface properties of BG-PVA/bone composite implants in simulated body fluid.
Ma Y; Zheng Y; Huang X; Xi T; Lin X; Han D; Song W
Biomed Mater; 2010 Apr; 5(2):25003. PubMed ID: 20208130
[TBL] [Abstract][Full Text] [Related]
18. Self-reinforced composites of bioabsorbable polymer and bioactive glass with different bioactive glass contents. Part I: Initial mechanical properties and bioactivity.
Niemelä T; Niiranen H; Kellomäki M; Törmälä P
Acta Biomater; 2005 Mar; 1(2):235-42. PubMed ID: 16701800
[TBL] [Abstract][Full Text] [Related]
19. Porous polymer/bioactive glass composites for soft-to-hard tissue interfaces.
Zhang K; Ma Y; Francis LF
J Biomed Mater Res; 2002 Sep; 61(4):551-63. PubMed ID: 12115445
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of bioactive and biodegradable wollastonite/poly(D,L-lactic acid) composite scaffolds.
Li H; Chang J
J Mater Sci Mater Med; 2004 Oct; 15(10):1089-95. PubMed ID: 15516869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
